Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials.
- DOI
- 10.1093/ecco-jcc/jjae079
- Published
- 2024 Nov 4
- Container
- Journal of Crohn's & colitis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ecco-jcc/jjae079,
title = {Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials.},
author = {Vermeire S and Sands BE and Peyrin-Biroulet L and D'Haens GR and Panés J and Yarur AJ and Wolf DC and Ritter T and Schreiber S and Woolcott JC and Modesto I and Keating M and Shan K and Wu J and Chiorean MV and Baert F and Dubinsky MC and Goetsch M and Danese S and Feagan BG},
year = {2024},
journal = {Journal of Crohn's \& colitis},
doi = {10.1093/ecco-jcc/jjae079},
url = {https://doi.org/10.1093/ecco-jcc/jjae079}
}RIS
TY - JOUR TI - Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials. AU - Vermeire S AU - Sands BE AU - Peyrin-Biroulet L AU - D'Haens GR AU - Panés J AU - Yarur AJ AU - Wolf DC AU - Ritter T AU - Schreiber S AU - Woolcott JC AU - Modesto I AU - Keating M AU - Shan K AU - Wu J AU - Chiorean MV AU - Baert F AU - Dubinsky MC AU - Goetsch M AU - Danese S AU - Feagan BG PY - 2024 JO - Journal of Crohn's & colitis DO - 10.1093/ecco-jcc/jjae079 UR - https://doi.org/10.1093/ecco-jcc/jjae079 ER -
APA
S, V., BE, S., L, P., GR, D., J, P., AJ, Y., DC, W., T, R., S, S., JC, W., I, M., M, K., K, S., J, W., MV, C., F, B., MC, D., M, G., S, D., & BG, F. (2024). Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials.. Journal of Crohn's & colitis. https://doi.org/10.1093/ecco-jcc/jjae079
Source records
- pubmed · retrieved 2026-09-25T23:01:39.250Z
- europe-pmc · retrieved 2026-09-25T23:01:39.246Z